Presentation slides from the Mountain West AETC's CROI 2020 review (4/9/20) on dual antiretroviral therapy (ART) & HIV cure. Slides review the following:
Dual ART
- Dolutegravir/lamivudine initial ART: updated 96-week results
- Islatravir + doravirine metabolic outcomes at 48 weeks
HIV Cure
- Sustained HIV remission in the London Patient
Documents
Browse more
Language: English
Topic(s): Antiretroviral Therapy, Step 6: Treatment Success--Suppressed Viral Load, Adult Learning
Resource type: Slide Sets
Add comment